Clinical Trials Browser

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Phase 2 Not yet recruiting

20 enrolled

Head & Neck

Thyroid Neoplasms

NCT05520619 2024-11-18

EC-CRT-002

Phase 2 Active not recruiting

114 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06588335 2024-09-19

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

20 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04005170 2022-08-23

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Phase 2 Completed

42 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04625543 2022-04-26

Neoadjuvant Immunotherapy to ESCC

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Phase 2 Terminated

21 enrolled 7 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

44 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT00933387 2016-05-04

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

Phase 2 Completed

47 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT02133612 2015-04-14

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Completed

43 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01444547 2014-05-06

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Phase 2 Unknown

92 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Phase 2 Terminated

39 enrolled

Thoracic

Thymic epithelial tumor, Thymoma

NCT00680940 2012-08-07

NSCLC

Phase 2 Completed

221 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

EC-CRT-006

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

EC-CRT-002

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Neoadjuvant Immunotherapy to ESCC

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Paclitaxel and Cisplatin for Thymic Neoplasm

NSCLC